PL1807048T3 - Kompozycja odwróconych miceli do dostarczania kationów metali zawierająca digliceryd i fitosterol oraz sposób wytwarzania - Google Patents

Kompozycja odwróconych miceli do dostarczania kationów metali zawierająca digliceryd i fitosterol oraz sposób wytwarzania

Info

Publication number
PL1807048T3
PL1807048T3 PL05804076T PL05804076T PL1807048T3 PL 1807048 T3 PL1807048 T3 PL 1807048T3 PL 05804076 T PL05804076 T PL 05804076T PL 05804076 T PL05804076 T PL 05804076T PL 1807048 T3 PL1807048 T3 PL 1807048T3
Authority
PL
Poland
Prior art keywords
preparation
phytosterol
delivery
metal cations
reverse micelle
Prior art date
Application number
PL05804076T
Other languages
English (en)
Polish (pl)
Inventor
Jean-Claude Maurel
Original Assignee
Medesis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma filed Critical Medesis Pharma
Publication of PL1807048T3 publication Critical patent/PL1807048T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
PL05804076T 2004-11-02 2005-11-02 Kompozycja odwróconych miceli do dostarczania kationów metali zawierająca digliceryd i fitosterol oraz sposób wytwarzania PL1807048T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04025987A EP1652512A1 (en) 2004-11-02 2004-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
PCT/IB2005/003605 WO2006048773A1 (en) 2004-11-02 2005-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
EP05804076A EP1807048B1 (en) 2004-11-02 2005-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Publications (1)

Publication Number Publication Date
PL1807048T3 true PL1807048T3 (pl) 2011-03-31

Family

ID=34927200

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05804076T PL1807048T3 (pl) 2004-11-02 2005-11-02 Kompozycja odwróconych miceli do dostarczania kationów metali zawierająca digliceryd i fitosterol oraz sposób wytwarzania

Country Status (16)

Country Link
US (1) US9173838B2 (https=)
EP (2) EP1652512A1 (https=)
JP (1) JP4975631B2 (https=)
CN (1) CN101102751B (https=)
AT (1) ATE483454T1 (https=)
AU (1) AU2005300253B2 (https=)
CA (1) CA2584684C (https=)
DE (1) DE602005024036D1 (https=)
DK (1) DK1807048T3 (https=)
EA (1) EA012210B1 (https=)
ES (1) ES2353804T3 (https=)
IL (1) IL182756A (https=)
PL (1) PL1807048T3 (https=)
PT (1) PT1807048E (https=)
WO (1) WO2006048773A1 (https=)
ZA (1) ZA200704286B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof
CA2792136C (en) 2010-03-24 2020-08-04 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
BRPI1000970A2 (pt) * 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders
WO2017005899A1 (en) * 2015-07-09 2017-01-12 Medesis Pharma In situ preparation of cyano-bridged metal nanop articles within a biocompatible reverse micellar system
CN112672735A (zh) * 2018-07-06 2021-04-16 麦迪西斯医药公司 对由辐射暴露引起的损伤的治疗和预防
WO2024184369A1 (en) * 2023-03-06 2024-09-12 Medesis Pharma Formulation for the buccal administration of a biocompatible reverse micelle system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
JPH119988A (ja) * 1997-06-26 1999-01-19 Advanced Sukin Res Kenkyusho:Kk 油中水型マイクロエマルション
JPH1129464A (ja) * 1997-07-07 1999-02-02 Advanced Sukin Res Kenkyusho:Kk コレステロールを添加する油中水型マイクロエマルション
WO2000057721A2 (en) * 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
AU2002231724B2 (en) * 2001-01-25 2005-10-20 Unilever Plc Microemulsions
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
EP1452175A1 (en) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
CN1457773A (zh) * 2003-06-02 2003-11-26 乐益 治疗糖尿病的双胍钒络合物颗粒剂和/或胶囊剂及其用途
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof

Also Published As

Publication number Publication date
WO2006048773A1 (en) 2006-05-11
EA012210B1 (ru) 2009-08-28
HK1108368A1 (en) 2008-05-09
ES2353804T3 (es) 2011-03-07
AU2005300253A1 (en) 2006-05-11
EP1807048B1 (en) 2010-10-06
IL182756A (en) 2011-02-28
ATE483454T1 (de) 2010-10-15
IL182756A0 (en) 2007-07-24
JP2008519026A (ja) 2008-06-05
ZA200704286B (en) 2008-09-25
EP1807048A1 (en) 2007-07-18
JP4975631B2 (ja) 2012-07-11
CN101102751A (zh) 2008-01-09
US9173838B2 (en) 2015-11-03
CN101102751B (zh) 2011-08-24
CA2584684A1 (en) 2006-05-11
AU2005300253B2 (en) 2010-09-09
PT1807048E (pt) 2010-11-29
CA2584684C (en) 2013-07-02
EA200700994A1 (ru) 2007-10-26
EP1652512A1 (en) 2006-05-03
US20090087477A1 (en) 2009-04-02
DE602005024036D1 (de) 2010-11-18
DK1807048T3 (da) 2011-01-10

Similar Documents

Publication Publication Date Title
ZA200704286B (en) Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
WO2006105112A3 (en) Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
AR060163A1 (es) Micelas de proteina de suero
BR0212871A (pt) Concentrado fomador de microemulsão, microemulsão e métodos de aplicar uma composição herbicida e um herbicida e de preparar um concentrado formador de microemulsão e uma microemulsão
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
IL181632A0 (en) Microemulsion & sud-micron emulsion process & compositions
EP2045900A3 (en) Flux-switching machine
PA8545301A1 (es) Nuevos derivados de quinolina
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
ATE514345T1 (de) Zusammensetzung zur senkung des blutcholesterolspiegels
WO2006010423A3 (en) Azaindole inhibitors of mtp and apob
DE502005006022D1 (de) Amphotere ethylmethacrylat-copolymere und deren verwendung
AR077264A1 (es) Metodo para producir un ester de fitoesterol y/o un ester de fitoestanol
WO2008070141A3 (en) Compositions for delivery of therapeutic agents
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
DE60204078D1 (de) Konzentrat von Triterpenen
ATE500835T1 (de) Entzündungshemmende zusammensetzungen und anwendungsverfahren
GB0522942D0 (en) Dissolution composition
MXPA05008572A (es) Uso de dipiridamol en combinacion con acido acetilsalicilico y un antagonista de angiotensina ii para la prevencion de accidente cerebrovascular.
PL1742927T3 (pl) Pochodne kwasu butanowego, sposoby ich otrzymywania, kompozycje farmaceutyczne zawierające takie pochodne i terapeutyczne zastosowanie takich pochodnych
DE602007002591D1 (de) Neue Naphtalinderivate, ihr Herstellungsverfahren und die pharmazeutischen Zusammensetzungen, die sie enthalten
ZA200704318B (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
WO2004074427A3 (en) Three dimensional model for protein or part of protein structure